https://compoundlibraries.com/....index.php/control-ov
Currently, there is a lack of a safe and effective medication for managing SLE. Potent anti-inflammatory activity and NF-κB inhibition are displayed by the quinazoline derivative N4-(4-phenoxyphenethyl)quinazoline-46-diamine, also known as QNZ. However, the ability of QNZ treatment to modify B cell activation and the seriousness of SLE is not established. Flow cytometric analyses were performed to examine the expression of activation and antigen presentation-re
Like
Comment
Share
